Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00975520 · ClinicalTrials.gov registry record · NA

Neurotropic Melanoma of the Head and Neck

A NA study, sponsored by Melanoma and Skin Cancer Trials Limited.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT00975520: Completed NA study, sponsored by Melanoma and Skin Cancer Trials Limited.

NCT00975520 is a NA study that has completed, run by Melanoma and Skin Cancer Trials Limited. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00975520, a NA study, has completed, sponsored by Melanoma and Skin Cancer Trials Limited.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

This is a 2-armed randomised controlled trial comparing surgery alone with surgery plus post-operative radiation therapy for patients with completely resected primary melanoma showing histological features of neurotropism. Uncontrolled studies suggest that this form of primary melanoma has a high risk of local recurrence and that postoperative radiation therapy may substantially reduce that risk. Patients who are eligible on the basis of the pathology of the excised melanoma will be offered the opportunity to take part in the trial. Those randomised to receive radiation therapy will be treated with a simple technique encompassing the surgical bed plus a margin. Radiation will commence within 3 months of surgery (maximum of 14 weeks from surgery to start of radiotherapy).

Interventions

  • OTHER Observation
  • RADIATION Radiation Therapy

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2009-09
Est. Completion 2023-03
Phase NA

What the finished NCT00975520 record still lists

NCT00975520 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Observation is the first listed.

NCT00975520 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00975520 about?

NCT00975520 is a clinical study titled "Neurotropic Melanoma of the Head and Neck". This is a 2-armed randomised controlled trial comparing surgery alone with surgery plus post-operative radiation therapy for patients with completely resected primary melanoma showing histological features of neurotropism. Uncontrolled studies suggest that this form of primary melanoma has a high ri...

What is the current status of trial NCT00975520?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2009-09. Estimated completion is 2023-03.

What interventions are being tested in trial NCT00975520?

The interventions under investigation include: Observation (OTHER), Radiation Therapy (RADIATION).

Who is sponsoring clinical trial NCT00975520?

This trial is sponsored by Melanoma and Skin Cancer Trials Limited, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00975520's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00975520, the US trial registry maintained by the National Library of Medicine. NCT00975520 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.